Additionally, our findings suggest a critical role of TRIB3 in the modulation of ferroptosis, where inhibiting TRIB3 activity potentiates the sensitivity of cancer cells to ferroptosis inducers, such as erastin, which is correlated with reduced ferrous iron and GSH levels. The gene discussed is TRIB3; the disease is cancer.